Volunteers were randomized to either receive a placebo or one of three varying doses of orforglipron, taken once a day (as is common with GLP-1 therapy, people gradually reached their maximum dose over time)
Consider consulting with a healthcare professional to discuss your symptoms and lifestyle
As of Thursday, no shipping notification had been sent
For patients with food addiction features, this neurologic effect may be the most powerful aspect of therapy
11 John Cronin, MD, senior vice president of clinical development at Apnimed, underscores the need for diverse treatment options
Longato E, Di Camillo B, Sparacino G, Tramontan L, Avogaro A, Fadini GP